Astellas Pharma, Inc. (ALPMY)
16.84
+0.34
(+2.03%)
USD |
OTCM |
Nov 13, 16:00
Astellas Pharma Price to Book Value : 2.395 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 2.395 |
| November 12, 2026 | 2.347 |
| November 11, 2026 | 2.343 |
| November 10, 2026 | 2.333 |
| November 09, 2026 | 2.347 |
| November 06, 2026 | 2.249 |
| November 05, 2026 | 2.330 |
| November 04, 2026 | 2.278 |
| November 03, 2026 | 2.292 |
| November 02, 2026 | 2.305 |
| October 30, 2026 | 2.298 |
| October 29, 2026 | 2.275 |
| October 28, 2026 | 2.258 |
| October 27, 2026 | 2.266 |
| October 26, 2026 | 2.313 |
| October 23, 2026 | 2.268 |
| October 22, 2026 | 2.242 |
| October 21, 2026 | 2.229 |
| October 20, 2026 | 2.201 |
| October 19, 2026 | 2.153 |
| October 16, 2026 | 2.151 |
| October 15, 2026 | 2.120 |
| October 14, 2026 | 2.040 |
| October 13, 2026 | 2.046 |
| October 12, 2026 | 2.040 |
| Date | Value |
|---|---|
| October 09, 2026 | 2.040 |
| October 08, 2026 | 2.019 |
| October 07, 2026 | 2.025 |
| October 06, 2026 | 2.012 |
| October 05, 2026 | 2.020 |
| October 02, 2026 | 2.036 |
| October 01, 2026 | 2.053 |
| September 30, 2026 | 2.057 |
| September 29, 2026 | 2.220 |
| September 28, 2026 | 2.243 |
| September 25, 2026 | 2.283 |
| September 24, 2026 | 2.232 |
| September 23, 2026 | 2.259 |
| September 22, 2026 | 2.303 |
| September 21, 2026 | 2.282 |
| September 18, 2026 | 2.277 |
| September 17, 2026 | 2.279 |
| September 16, 2026 | 2.215 |
| September 15, 2026 | 2.229 |
| September 14, 2026 | 2.228 |
| September 11, 2026 | 2.184 |
| September 10, 2026 | 2.133 |
| September 09, 2026 | 2.165 |
| September 08, 2026 | 2.204 |
| September 04, 2026 | 2.258 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 1.451 |
| Daiichi Sankyo Co., Ltd. | 2.927 |
| Eisai Co., Ltd. | 1.604 |
| Chugai Pharmaceutical Co., Ltd. | 5.573 |
| Santen Pharmaceutical Co., Ltd. | 2.105 |
Price to Book Value Related Metrics
| PE Ratio | 12.38 |
| PS Ratio | 2.004 |
| PEG Ratio | 0.0671 |
| Price to Free Cash Flow | 10.84 |
| Price | 16.84 |
| Earnings Yield | 8.08% |
| Market Cap | 30.21B |
| PEGY Ratio | 0.0671 |
| Operating PE Ratio | 8.589 |
| Normalized PE Ratio | 12.38 |